What 4 Analyst Ratings Have To Say About Mustang Bio
Portfolio Pulse from Benzinga Insights
Mustang Bio (NASDAQ:MBIO) has received four bullish ratings from analysts in the last quarter. The company's average 12-month price target is $21.5, with a high of $25.00 and a low of $16.00. This average price target has increased by 79.17% over the past month.
August 15, 2023 | 4:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Mustang Bio has received positive ratings from analysts, which could potentially boost its stock price.
Analyst ratings often influence investor sentiment and can impact a company's stock price. In this case, Mustang Bio has received four bullish ratings, which indicates a positive outlook for the company. This could potentially lead to an increase in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100